Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AMG 673 |
| Synonyms | |
| Therapy Description |
AMG 673 s a bispecific antibody that targets both CD33 and CD3, resulting in cytotoxic activity against CD33-positive cells (PMID: 29534618). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AMG 673 | AMG673|AMG-673 | CD3 Antibody 119 CD33 Antibody 17 | AMG 673 s a bispecific antibody that targets both CD33 and CD3, resulting in cytotoxic activity against CD33-positive cells (PMID: 29534618). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03224819 | Phase I | AMG 673 | Study of AMG 673 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia | Terminated | USA | DEU | AUS | 0 |